An elite-growth healthcare technology business generating exceptional free cash flow despite GAAP losses, with four consecutive earnings beats and 47% revenue growth — but the stock has effectively reached the analyst consensus target, leaving thin upside and an 82% partner contract concentration that warrants caution at current prices.
Thesis pillars
- Elite Fcf Despite Gaap Losses→Stable
- Partner Concentration Structural Risk→Stable
- Hypergrowth Revenue Trajectory→Stable
- +1 more pillar — see the Why tab for full reasoning
Hinge Health, Inc. (HNGE) Stock Analysis
Healthcare · Health Information Services
Sell if holding. Engine safety override at $84.05: a dimension score below its floor triggers a hard block regardless of the otherwise-positive setup — overall score 5.6/10. Specifically: High short interest: 11%; Elevated put/call ratio: 2.18.
Hinge Health delivers AI-powered musculoskeletal care through a digital platform serving self-insured employers, health plans, and Medicare Advantage populations with programs across 16 body areas. Revenue is earned primarily through per-member fees under multi-year contracts;... Read more
Sell if holding. Engine safety override at $84.05: a dimension score below its floor triggers a hard block regardless of the otherwise-positive setup — overall score 5.6/10. Specifically: High short interest: 11%; Elevated put/call ratio: 2.18. Chart setup: No clear chart pattern; technical signals are mixed. Score 5.6/10, moderate confidence.
Passes 5/8 gates (positive momentum, news events none recent, earnings proximity 32d clear, semi cycle peak clear, materials cycle peak clear). Fails on favorable risk/reward ratio and clean insider activity. Suitability: moderate.
About Hinge Health, Inc.
About Hinge Health, Inc.
Hinge Health contracted more than 22 million employer lives and served over 60 health plan and PBM partners as of December 31, 2025, making it one of the larger digital MSK platforms by enrolled population. The company expanded its care platform to 16 affected body areas—from neck to ankle—and launched HingeSelect, an in-person MSK care provider network, in 2025. Net losses reached $528.3 million in fiscal 2025, with an accumulated deficit of $1.05 billion since inception.
Hinge Health earns fees from self-insured employers, fully insured health plan populations, and Medicare Advantage plans under contracts averaging three years in length. Eighty-two percent of 2025 revenue flowed through partner agreements with health plans and PBMs, with Health Care Service Corporation (HCSC), Elevance Health (formerly Anthem), and Aetna Life Insurance Company accounting for 17.5%, 13.7%, and 10.5% of revenue, respectively. The AI-powered care model—anchored by TrueMotion motion tracking technology and the FDA-cleared Enso electrical nerve stimulation wearable—reduced human physical therapy hours by an estimated 97% per 2025 internal data. Revenue is recognized ratably over annual subscriptions, and the company is transitioning certain clients to an engagement-based pricing model that could introduce variability in near-term recognized revenue. Most client contracts are three years in length and health plan partner relationships can be unilaterally terminated before expiration.
Show full overview
The three largest health plan partners—HCSC at 17.5%, Elevance at 13.7%, and Aetna at 10.5% of 2025 revenue—each hold contractual ability to unilaterally terminate their agreements per the 10-K. With 82% of revenue running through partner relationships, a loss of any top-three partner could expose Hinge Health to a revenue gap that its 51-person direct employer sales force may take multiple contract cycles to offset. These three partners each individually exceeded 10% of annual revenue in both 2024 and 2025, indicating sustained rather than one-time dependency.
See also: Healthcare · Health Information Services
From Hinge Health, Inc.'s most recent 10-K filing, extracted June 10, 2026.
Recent developments
updated 2026-07-06Recent Developments — Hinge Health, Inc.
Latest news
- NEWS Why Hinge Health Inc. (HNGE) Might be Well Poised for a Surge - Yahoo Finance — Yahoo Finance positive
- NEWS Hinge Health Inc (HNGE) Valuation: PE, PB & Fair Value Analysis - TradingKey — TradingKey neutral
- NEWS Hinge Health Inc (HNGE) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey — TradingKey neutral
- NEWS HNGE Stock Up on Q1 Earnings & Revenue Beat, 2026 Outlook Improved - Zacks Investment Research — Zacks Investment Research positive
- NEWS Hinge Health (NYSE:HNGE) Given New $63.00 Price Target at Needham & Company LLC - MarketBeat — MarketBeat positive
Generated 2026-07-06T04:40:27Z.
Upcoming dated catalysts
Thesis
Key Metrics
Quality Signals
Options Flow
Concentration Risks(10-K Item 1A)
- HIGHCustomerpartner contracts82%10-K Item 1A: 'Client contracts through our partners accounted for 82% of our revenue for the year ended December 31, 2025'
- LOWCustomerHCSC18%10-K Item 1A: 'client contracts through (i) Health Care Service Corporation ("HCSC") accounted for 17.5% and 17.1% of our revenue, respectively'
- LOWCustomerElevance14%10-K Item 1A: '(ii) Elevance Health, Inc., formerly known as Anthem, Inc. ("Elevance"), accounted for 13.7% and 14.0% of our revenue, respectively'
- LOWCustomerAetna11%10-K Item 1A: '(iii) Aetna Life Insurance Company ("Aetna") accounted for 10.5% and 11.6% of our revenue, respectively'
Material Events(8-K, last 90d)
- 2026-03-17Item 5.02LOWTyler Sloat appointed as Class I Director effective March 16, 2026; named Chair of Compensation Committee and member of Audit Committee. Previously CFO of Freshworks Inc. (since 2020) and Zuora Inc. No departures cited.SEC filing →
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
Rating Breakdown
3 floor-breakers·1 ceiling hit
Risk profile below the gate floor. Component breakdown shows what dragged the score down.static
Ranks in the bottom of its industry peers on the composite signal. Better names in the same sector exist.static
Technicals below the gate floor. Component breakdown shows what dragged the score down.static
Price Targets
Position Sizing
Risk Alerts
Earnings
Verdict History
Frequently Asked Questions
Sell if holding. Engine safety override at $84.05: a dimension score below its floor triggers a hard block regardless of the otherwise-positive setup — overall score 5.6/10. Specifically: High short interest: 11%; Elevated put/call ratio: 2.18. Chart setup: No clear chart pattern; technical signals are mixed. Prior stop was $78.17. Score 5.6/10, moderate confidence.
Take-profit target: $84.93 (+1.0% upside). Prior stop was $78.17. Stop-loss: $78.17.
Concentration risk — Customer: partner contracts (82.0%); Target reached (-12.1% upside); Risk below floor (2.8 < 3.0).
Hinge Health, Inc. trades at a P/E of N/A (forward 24.8). TrendMatrix value score: 5.0/10. Verdict: Sell.
22 analysts cover HNGE with a consensus score of 4.1/5. Average price target: $82.
What does Hinge Health, Inc. do?Hinge Health delivers AI-powered musculoskeletal care through a digital platform serving self-insured employers, health...
Hinge Health delivers AI-powered musculoskeletal care through a digital platform serving self-insured employers, health plans, and Medicare Advantage populations with programs across 16 body areas. Revenue is earned primarily through per-member fees under multi-year contracts; 82% of 2025 revenue was channeled through health plan and PBM partners. The company had over 22 million contracted employer lives and over 60 partners as of December 31, 2025.